TOPICAL NANOEMULSIONS AS EFFECTIVE DRUG CARIERS Rai V., et al.“Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery”Journal of Controlled Release Volume 270, 28 January 2018, Pages 203-225 TARGETED FOLLICULAR DELIVERY MINOXIDIL-FINASTERIDE TOPICAL NANOEMULSION •Water based formulation (oil-in-water nanoemulsion) …
Glucose-lowering activity of insulin-loaded SNEDDS in a compressed sublingual tablet Copyright © 2026 PHARCON Inc. – All Rights Reserved.
PLGA MICROPARTICLES WITH GLATIRAMER (COPAXONE® LAI) Despite several methods for preparation of injectable microparticles with incorporated water-soluble component are described, the most appropriate process based on “double emulsification” approach was selected. Briefly, the concentrated water solution of the highly water-soluble…
Copyright © 2026 PHARCON Inc. – All Rights Reserved.
Overview. This figure compares the dominant bioavailability barriers and formulation strategies associated with ral and non-oral drug delivery routes. While oral administration remains the most patient-preferred route, it imposes multiple sequential physiological and biochemical barriers. Non-oral routes bypass some or…
This page is part of the legacy archive of our previous website and preserves the original slide presentation describing the Emulvit D nanoemulsion formulation. Although the layout reflects an older version of the site, the scientific content remains relevant and…
Scientific Background of Vitamin D3 Emulvit‑D is a Vitamin D3 concentrated nanoemulsion engineered for rapid and efficient absorption. This R&D overview summarizes the scientific background of cholecalciferol, vitamin D metabolism, and the technological advantages of nanoemulsion‑based delivery. Cholecalciferol (Vitamin D3)…
This 5-minute video presents a unified overview of Pharcon Inc.’s research and development portfolio, including patented technologies, formulation platforms, and delivery systems. It consolidates multiple presentations into a single visual summary. For more information, visit pharcon.ca. See the R&D section…
Controlled release and mucosal delivery systems offer alternative ways to deliver drugs with improved consistency, faster onset, or avoidance of first‑pass metabolism. This article explains oral and parenteral controlled release, as well as sublingual and buccal delivery, in simple terms—focusing…
Lipid-Based Nanocarriers Lipid‑based nanocarriers are one of the most widely used delivery systems in modern formulation science. This article explains the two major types—Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs)—in simple, practical terms, focusing on structure, mechanism, advantages,…
